Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Antonelli

Showing results (211-220 of 246) with videos related to

Pageof 25
Sort By:
Journal of Hepatology|May 1, 1989
Interleukin-2, interleukin-2 receptor and gamma-interferon synthesis by peripheral blood mononuclear cells in chronic hepatitis delta virus infectionS Magrin, A Craxì, C Carini, et al.
AIDS Research and Human Retroviruses|January 10, 2002
Decay of HIV type 1 DNA and development of drug-resistant mutants in patients with primary HIV type 1 infection receiving highly active antiretroviral therapyE Riva, M Pistello, P Narciso, et al.
La Clinica Terapeutica|May 31, 2001
[Second-line chemotherapy and new drugs for ovarian carcinoma]D Priolo, G Antonelli, S Calì, et al.
Infection|October 19, 2014
Detection and quantification of EBV, HHV-6 and CMV DNA in the gastrointestinal tract of HIV-positive patientsF Falasca, P Maida, A Gaeta, et al.
The American Journal of Gastroenterology|September 11, 1998
HCV genotypes and breakthrough in patients treated with recombinant alpha interferonL Roffi, G Colloredo, B Brugnetti, et al.
Scientific Reports|August 2, 2016
HCV derived from sera of HCV-infected patients induces pro-fibrotic effects in human primary fibroblasts by activating GLI2M Granato, C Zompetta, E Vescarelli, et al.
Clinical and Experimental Immunology|June 1, 1996
Antibodies to interferon (IFN) in hepatitis C patients relapsing while continuing recombinant IFN-alpha2 therapyG Antonelli, G Giannelli, M Currenti, et al.
Progress in Clinical and Biological Research|January 1, 1993
Lymphoblastoid interferon in patients with chronic nAnB hepatitis showing relapse during recombinant alpha interferon therapyG C Mels, L Roffi, G Antonelli, et al.
Annali Di Igiene : Medicina Preventiva E Di Comunita|May 1, 1989
[Acid-labile alpha interferon produced by peripheral blood mononuclear cells stimulated by cells infected by HIV]F Dianzani, M R Capobianchi, F De Marco, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|June 10, 1998
Development of neutralizing antibodies in patients with relapsing-remitting multiple sclerosis treated with IFN-beta1aG Antonelli, F Bagnato, C Pozzilli, et al.
Pageof 25

Showing results (211-220 of 246) with videos related to

Sort By:
Pageof 25
Journal of Hepatology|May 1, 1989
Interleukin-2, interleukin-2 receptor and gamma-interferon synthesis by peripheral blood mononuclear cells in chronic hepatitis delta virus infectionS Magrin, A Craxì, C Carini, et al.
AIDS Research and Human Retroviruses|January 10, 2002
Decay of HIV type 1 DNA and development of drug-resistant mutants in patients with primary HIV type 1 infection receiving highly active antiretroviral therapyE Riva, M Pistello, P Narciso, et al.
La Clinica Terapeutica|May 31, 2001
[Second-line chemotherapy and new drugs for ovarian carcinoma]D Priolo, G Antonelli, S Calì, et al.
Infection|October 19, 2014
Detection and quantification of EBV, HHV-6 and CMV DNA in the gastrointestinal tract of HIV-positive patientsF Falasca, P Maida, A Gaeta, et al.
The American Journal of Gastroenterology|September 11, 1998
HCV genotypes and breakthrough in patients treated with recombinant alpha interferonL Roffi, G Colloredo, B Brugnetti, et al.
Scientific Reports|August 2, 2016
HCV derived from sera of HCV-infected patients induces pro-fibrotic effects in human primary fibroblasts by activating GLI2M Granato, C Zompetta, E Vescarelli, et al.
Clinical and Experimental Immunology|June 1, 1996
Antibodies to interferon (IFN) in hepatitis C patients relapsing while continuing recombinant IFN-alpha2 therapyG Antonelli, G Giannelli, M Currenti, et al.
Progress in Clinical and Biological Research|January 1, 1993
Lymphoblastoid interferon in patients with chronic nAnB hepatitis showing relapse during recombinant alpha interferon therapyG C Mels, L Roffi, G Antonelli, et al.
Annali Di Igiene : Medicina Preventiva E Di Comunita|May 1, 1989
[Acid-labile alpha interferon produced by peripheral blood mononuclear cells stimulated by cells infected by HIV]F Dianzani, M R Capobianchi, F De Marco, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|June 10, 1998
Development of neutralizing antibodies in patients with relapsing-remitting multiple sclerosis treated with IFN-beta1aG Antonelli, F Bagnato, C Pozzilli, et al.
Pageof 25